Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
To match the metabolic demands of the brain, mechanisms have evolved to couple neuronal activity to vasodilation, thus increasing local cerebral blood flow and delivery of oxygen and glucose to active neurons. Rather than relying on metabolic feedback signals such as the consumption of oxygen or glucose, the main signalling pathways rely on the release of vasoactive molecules by neurons and astrocytes, which act on contractile cells. Vascular smooth muscle cells and pericytes are the contractile cells associated with arterioles and capillaries, respectively, which relax and induce vasodilation. Much progress has been made in understanding the complex signalling pathways of neurovascular coupling, but issues such as the contributions of capillary pericytes and astrocyte calcium signal remain contentious. Study of neurovascular coupling mechanisms is especially important as cerebral blood flow dysregulation is a prominent feature of Alzheimer’s disease. In this article we will discuss developments and controversies in the understanding of neurovascular coupling and finish by discussing current knowledge concerning neurovascular uncoupling in Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589 · cited 1×
“This validated a large body of work supporting pericyte loss and subsequent BBB dysfunction as a key step in driving neuronal loss and Alzheimer’s disease-like pathology.(155,166) There are myriad proposed mechanisms of how loss of BBB integrity contributes to neuronal death, which are reviewed in depth elsewhere,(167…”
BackgroundRetractedThe cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 1×
“significant finding given the early cortical and hippocampal loss of cholinergic innervation in Alzheimer’s disease.(132) Furthermore, Nizari et al.”
BackgroundNitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · cited 2×
“which is in line with the observation that the cerebellum is usually affected in later stages of the disease.(130) Recently, Nizari et al.”
BackgroundResultAlzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Glial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511 · cited 6×
“tamate receptor 5 (mGluR5) activation by glutamate released at the synapse is responsible for this calcium signal.(2) However, sev-”
BackgroundMethodInfluentialThe Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Fox, P. T., & Raichle, M. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1140 · Cited by 2,056 · cited 1×
“It should be noted that thehyperaemic response exceeds the increase in cerebral metabolism by 6-fold, although it is possible that the brief period of increased demand that precedes the CBF increase is sufficient for transient changes in metabolite levels to evoke this change.(55) It has been shown that the depletion…”
BackgroundA molecular atlas of cell types and zonation in the brain vasculature
Vanlandewijck, M., He, L., Mäe, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Nature · doi:10.1038/nature25739 · Cited by 1,892 · cited 1×
“osin expression but absent or very low expression of Acta2 (αSMA).(74) Nevertheless, a recent study has shown that following optogenetic stimulation, pericytes exert a slow vasoconstriction that slows red blood cell flux.”
BackgroundCapillary pericytes regulate cerebral blood flow in health and disease
Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., O’Farrell, F. M., Buchan, A. M., Lauritzen, M., & Attwell, D. (2014) · Nature · doi:10.1038/nature13165 · Cited by 1,870
Self-citationBell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · cited 1×
“This validated a large body of work supporting pericyte loss and subsequent BBB dysfunction as a key step in driving neuronal loss and Alzheimer’s disease-like pathology.(155,166) There are myriad proposed mechanisms of how loss of BBB integrity contributes to neuronal death, which are reviewed in depth elsewhere,(167…”
BackgroundPatterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328 · cited 1×
“For instance, APOE4 carriers have been reported to have increased amplitude and regional extent of activation in fMRI during memory tasks in the absence of diagnosed cognitive impairment.(110) Others have found that high-risk subjects (based on APOE4 carrier status and family history) have decreased inferotemporal act…”
BackgroundAPOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2247-3 · Cited by 1,281
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243 · cited 12×
“It is widely accepted that nitric oxide (NO) is a major mediator of NVC.2,10 Indeed, a systematic review by Hosford and Gourine13, which analysed data from in vivo experiments exploring the effect of pharmacological or genetic knockout of proposed signalling pathways, concluded that blockade of neuronal NO synthase (n…”
BackgroundInfluentialIturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202 · cited 3×
“The two-hit vascular hypothesis for Alzheimer’s disease progression proposes that NVD promotes Aβ pathology, and Aβ peptides in turn have deleterious effects on the cerebral vasculature (forming a positive feedback loop).5 In support of this hypothesis, in the Alzheimer’s Disease Neuroimaging Initiative Iturria-Medina…”
BackgroundResultInfluentialBidirectional control of CNS capillary diameter by pericytes
Peppiatt, C. M., Howarth, C., Mobbs, P., & Attwell, D. (2006) · Nature · doi:10.1038/nature05193 · Cited by 1,150
Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987
The neural basis of functional brain imaging signals
Attwell, D., & Iadecola, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02264-6 · Cited by 957
A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk
Yang, A. C., Vest, R. T., Kern, F., Lee, D. P., Agam, M., Maat, C. A., Losada, P. M., Chen, M. B., Schaum, N., Khoury, N., et al. (2022) · Nature · doi:10.1038/s41586-021-04369-3 · Cited by 797
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Karran, E., & De Strooper, B. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00391-w · Cited by 742
Rombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005) · Human Brain Mapping · doi:10.1002/hbm.20160 · Cited by 734
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., et al. (2019) · Science · doi:10.1126/science.aav9518 · Cited by 682 · cited 13×
“The finding from Nortley et al.(92) that Aβ1-42 causes pericytes to constrict capillaries provides a possible mechanism for the observed reduction in capillary diameter found in APP/PS1 mice.”
BackgroundMethodResultInfluentialHalliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649 · cited 1×
“APOE4 carriers exhibit approximately seven times more extravascular fibrin deposits than APOE3 carriers.(151) Fibrin itself contributes to Alzheimer’s disease pathogenesis, both as a result of leakage into the brain parenchyma through a leaky BBB(169) and accumulation in brain microvessels in response to vascular inju…”
BackgroundAttwell, D., Mishra, A., Hall, C. N., O’Farrell, F. M., & Dalkara, T. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15610340 · Cited by 648
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603 · cited 1×
“This neurovascular uncoupling likely contributes to cognitive impairment as well as paving the way for ‘hit two’ of the two-hit vascular hypothesis by potentiating the effects of Aβ.(5,9,108) This is emphasized by studies in mice showing improvements in cognitive function in Alzheimer’s disease mice once NVC is restor…”
BackgroundCapillary K+-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow
Longden, T. A., Dabertrand, F., Koide, M., Gonzales, A. L., Tykocki, N. R., Brayden, J. E., Hill-Eubanks, D., & Nelson, M. T. (2017) · Nature Neuroscience · doi:10.1038/nn.4533 · Cited by 522
Cruz Hernández, J. C., Bracko, O., Kersbergen, C. J., Muse, V., Haft-Javaherian, M., Berg, M., Park, L., Vinarcsik, L. K., Ivasyk, I., Rivera, D. A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0329-4 · Cited by 508
Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain
van Veluw, S. J., Hou, S. S., Calvo-Rodriguez, M., Arbel-Ornath, M., Snyder, A. C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J. (2020) · Neuron · doi:10.1016/j.neuron.2019.10.033 · Cited by 500 · cited 1×
“use Cre-recombinase to achieve acute global pericyte KO, leading to reduced NVC Cerebrovascular amyloid deposits Displacement of astrocyte endfeet and increased arterial stiffness Van Veluw et al.(164) show that astrocyte-mediated NVC is disrupted in CAA affected vessels and that CAA-affected Alzheimer’s disease mouse…”
MethodPericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain
Kisler, K., Nelson, A. R., Rege, S. V., Ramanathan, A., Wang, Y., Ahuja, A., Lazic, D., Tsai, P. S., Zhao, Z., Zhou, Y., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4489 · Cited by 497 · cited 4×
“Furthermore, Kisler et al.(70) reported decreased global haemodynamic response to stimulation in pericyte-deficient mice, which was attributed to”
BackgroundMethodInfluentialMedeiros, R., Prediger, R. D. S., Passos, G. F., Pandolfo, P., Duarte, F. S., Franco, J. L., Dafre, A. L., Di Giunta, G., Figueiredo, C. P., Takahashi, R. N., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5047-06.2007 · Cited by 292
Nox2-Derived Reactive Oxygen Species Mediate Neurovascular Dysregulation in the Aging Mouse Brain
Park, L., Anrather, J., Girouard, H., Zhou, P., & Iadecola, C. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600491 · Cited by 275 · cited 1×
“tration by ROS (forming peroxynitrites, a mediator of nitrosative stress).(135) Katusic and Austin make the point that increased ROS are a feature of Alzheimer’s disease as well as the cardiovascular diseases that are risk factors for Alzheimer’s disease;(136) thus, it is conceivable that this oxidative environment re…”
BackgroundThe capillary bed offers the largest hemodynamic resistance to the cortical blood supply
Gould, I. G., Tsai, P., Kleinfeld, D., & Linninger, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16671146 · Cited by 252 · cited 1×
“branch order and vessel diameter), leading the authors to argue capillary dilationwould have the greatest influence onNVC.(90) Schmid and colleague’s findings agree that for superficial cortical layers the”
BackgroundIdentification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Shi, H., Koronyo, Y., Rentsendorj, A., Regis, G. C., Sheyn, J., Fuchs, D.-T., Kramerov, A. A., Ljubimov, A. V., Dumitrascu, O. M., Rodriguez, A. R., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02134-w · Cited by 230 · cited 1×
“has been found in post-mortem human biopsies of the hippocampus,(150) cortex(150,151) (although a recent study found no loss of frontal cortical pericytes compared to similar aged controls(152)) and retina.(153) There is also convincing mechanistic evidence: a very recent single-cell transcriptomic study has”
ResultAβ-peptides enhance vasoconstriction in cerebral circulation
Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., & Iadecola, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2417 · Cited by 202 · cited 5×
“In 2001, an in vivo study performed onmice demonstrated that topical application of Aβ reduced resting CBF.125 This group also showed that in vitro Aβ application induces the constriction of mouse brain arteries.”
BackgroundInfluentialAge-dependent rescue by simvastatin of Alzheimer’s disease cerebrovascular and memory deficits
Tong, X.-K., Lecrux, C., & Hamel, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0169-12.2012 · Cited by 160 · cited 1×
“This is emphasized by studies in mice showing improvements in cognitive function in Alzheimer’s disease mice once NVC is restored.(106,109) Understanding NVC in dementia is also crucial to our ability to interpret functional imaging, which has been widely used to probe the neural processing changes in cognitive impair…”
BackgroundGlial Cell Calcium Signaling Mediates Capillary Regulation of Blood Flow in the Retina
Biesecker, K. R., Srienc, A. I., Shimoda, A. M., Agarwal, A., Bergles, D. E., Kofuji, P., & Newman, E. A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1782-16.2016 · Cited by 144
Thal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.017 · Cited by 138 · cited 1×
“Mouse models of Alzheimer’s diseaserelated CAA show impaired hyperaemic response to various vasodilatory stimuli(162) as well as capillary occlusion and CBF disturbances.(163) This relationship may also be bidirectional, with loss of NVC impairing clearance of Aβ and predisposing to CAA.”
BackgroundNielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.007 · Cited by 119
Stobart, J. L. L., Lu, L., Anderson, H. D. I., Mori, H., & Anderson, C. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215929110 · Cited by 113
Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated by Amyloid-β
Palmer, J. C., Barker, R., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111760 · Cited by 110 · cited 1×
“Importantly, it has previously been demonstrated that ET-1 is upregulated in temporal cortical neurons and microvessels in post-mortem samples from Alzheimer’s disease patients.(145) As such, these findings have the potential for therapeutic benefit, but translation into human therapy remains distant and is complicate…”
BackgroundVascular ApoE4 impairs behavior by modulating gliovascular function
Yamazaki, Y., Liu, C.-C., Yamazaki, A., Shue, F., Martens, Y. A., Chen, Y., Qiao, W., Kurti, A., Oue, H., Ren, Y., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.019 · Cited by 71
Wells, J. A., Christie, I. N., Hosford, P. S., Huckstepp, R. T. R., Angelova, P. R., Vihko, P., Cork, S. C., Abramov, A. Y., Teschemacher, A. G., Kasparov, S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3787-14.2015 · Cited by 57 · cited 5×
“Wells et al.(44) used a lentiviral vector to overexpress transmem-”
BackgroundResultInfluentialZolochevska, O., & Taglialatela, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518142110 · Cited by 49
A human brain vascular atlas reveals diverse cell mediators of Alzheimer’s disease risk
Yang, A. C., Vest, R. T., Kern, F., Lee, D. P., Maat, C. A., Losada, P. M., Chen, M. B., Agam, M., Schaum, N., Khoury, N., et al. (2021) · doi:10.1101/2021.04.26.441262 · Cited by 48
Cited by
Inoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 329
Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29
“Together, these various mechanisms lead to hypoxia and reduce CBF, which contributes to neuronal dysfunction, synaptic loss, and hypometabolism [129,130].”
BackgroundPlastic vasomotion entrainment
Sasaki, D., Imai, K., Ikoma, Y., & Matsui, K. (2024) · eLife · doi:10.7554/elife.93721.3 · Cited by 6
Metadata
- Authors
- Zhu, W. M., Neuhaus, A., Beard, D. J., Sutherland, B. A., & DeLuca, G. C.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-05-13
- Volume
- 145
- Issue
- 7
- Pages
- 2276-2292
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W4280572794
- Cited by
- 133
- References
- 51
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.